GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ppargamma ligand binding domain in complex with tripropyltin

Analyse Crystal structure of ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3PO9
Type
protein
Length
510 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
XPT
Pockets
8 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26166% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein24969% helix, 5% strandP37231

Ligands and binding sites

  • XPT · 1-[chloro(dipropyl)-lambda~4~-sulfanyl]propane · ligand · 2 copies · chains A, B
  • PGO · S-1,2-propanediol · additive · 4 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14280.800.8752XPT
24740.790.8652XPT, PGO
34980.630.7652PGO
41450.580.8323empty
51620.550.8128empty

Interfaces

1 interface between chains.

  • A–B · 863 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3PO9 · Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.